IL-6, when combined with SARS-CoV-2 RNAaemia rather than with other markers such as SpO2/FiO2, CRP, and LDH, may be a pathological biomarker indicating deterioration of primary COVID-19 rather than secondary inflammation. The gene discussed is IL6; the disease is COVID-19.